Your browser doesn't support javascript.
loading
Progress of Hemophilia A Therapeutics in Korea / 임상소아혈액종양
Clinical Pediatric Hematology-Oncology ; : 17-22, 2018.
Article in English | WPRIM | ID: wpr-714203
ABSTRACT
Over the past several decades, hemophilia treatment in Korea has progressed dramatically. It has become possible to prevent hemophilia complications by maintenance treatment as well as on-demand treatment with the help of the National Health Insurance program. Treatment and prevention of hemorrhage, prevention of joint complications, treatment and prevention of infectious complications have greatly improved the quality of life and life expectancy of hemophilia patients. However, the development of inhibitor is the most serious and challenging complication of clotting factor replacement therapy, although immune tolerance regimens and bypassing agents have shown some efficacy in countering this complication. The development of novel methods of therapy, including the use of extended half-life factors and gene therapy, will further improve the outcome of hemophilia patients. Administering the right drug to the right patients with the right dose at the right time will be necessary for treating the patient. Achievement of optimal therapeutic goals will require continued cooperation between patients and medical staff.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Quality of Life / Factor VIII / Genetic Therapy / Life Expectancy / Half-Life / Hemophilia A / Hemorrhage / Immune Tolerance / Joints / Korea Limits: Humans Country/Region as subject: Asia Language: English Journal: Clinical Pediatric Hematology-Oncology Year: 2018 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Quality of Life / Factor VIII / Genetic Therapy / Life Expectancy / Half-Life / Hemophilia A / Hemorrhage / Immune Tolerance / Joints / Korea Limits: Humans Country/Region as subject: Asia Language: English Journal: Clinical Pediatric Hematology-Oncology Year: 2018 Type: Article